Technology Impact Award – Full Application

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with Unit

Memorial Deadline: Monday 9th, March 2020

External Deadline: Sunday 15th, March 2020


Description

BY INVITATION ONLY

The Cancer Research Institute Technology Impact Award provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Award winners will be selected based on the novelty, creativity, technical sophistication, and transformative potential of the technology to impact cancer immunotherapy research around the world. The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time—developing immunotherapies that are effective for all cancer patients.

Additional information can be found here. 


Funding Sources

Cancer Research Institute



This opportunity was posted by: RGCS

Last modified: September 16, 2019